Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by Thereson Nov 17, 2009 5:31pm
513 Views
Post# 16496999

Diluton?

Diluton?

Stem Cell 18.22-million-unit private placement

2009-11-17 16:17 ET - Private Placement

The TSX Venture Exchange has accepted for filing documentation with respect to a brokered private placement announced Oct. 8 and Oct. 29, 2009.

Shares:  18,224,507 units, with each unit consisting of one common share and one common share purchase warrant

Purchase price:  12 cents

Warrants:  18,224,507 share purchase warrants to purchase 18,224,507 shares

Warrant exercise price:  15 cents for a one-year period

Hidden placees:  59

Insiders:  Alan Moore 200,000; Robert Rieder 50,000; Allen Davidoff 300,000; Barry Herring 50,000; Mark Wayne 500,000

Pro groups:  Wayne McNeill 1,567,500; James Mackie 833,334; Brenda Mackie 833,333; Jeffrey Mackie 150,000

Agents' fees:  $91,099 cash and 474,475 agent warrants payable to J.F. Mackie and Company Ltd.; $31,536 cash payable to MGI Securities Inc.; $43,200 cash payable to CIBC Wood Gundy

Bullboard Posts